Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/28/1993 | WO1993021209A1 Lactam peptides having hle inhibiting activity |
10/28/1993 | WO1993021208A1 Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments |
10/28/1993 | WO1993021184A1 Biphenylylquinuclidine derivatives as squalene synthase inhibitors |
10/28/1993 | WO1993021183A1 Quinuclidine derivatives as squalene synthase inhibitors |
10/28/1993 | WO1993021180A1 Acylaminoindole derivatives as 5-ht1 agonists |
10/28/1993 | WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same |
10/28/1993 | WO1993021155A1 Perhydroisoindole derivatives as p substance antagonists |
10/28/1993 | WO1993021149A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
10/28/1993 | WO1993020839A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality |
10/28/1993 | WO1993020807A1 Amines as inhibitors of squalene synthase |
10/28/1993 | WO1993020696A1 Regulation of the immune system |
10/28/1993 | CA2133840A1 Perhydroisoindole derivatives used as p substance antagonists |
10/28/1993 | CA2133659A1 Pyrimidinyl acetamides as elastase inhibitors |
10/28/1993 | CA2133658A1 Heterocyclic derivatives |
10/28/1993 | CA2133657A1 Substituted derivatives |
10/28/1993 | CA2133090A1 Endothelin antagonists ii |
10/28/1993 | CA2132543A1 Lactam dipeptides having hle inhibiting activity |
10/28/1993 | CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them |
10/28/1993 | CA2118253A1 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
10/28/1993 | CA2118250A1 Lactam peptides having hle inhibiting activity |
10/27/1993 | EP0567094A2 Hydrazoadenosines |
10/27/1993 | EP0566971A1 Use of L-carnitine for the treatment of shock |
10/27/1993 | EP0566673A1 Biosynthetic pdgf antagonists |
10/27/1993 | EP0566567A1 Antihypertensive benzopyran derivatives |
10/27/1993 | EP0479874B1 Use of norverapamil and norgallopamil as anti-arteriosclerosis drugs |
10/27/1993 | CN1077711A Cycloalkyl-and heterocyclyl-substituted imidazolylpropenoic acid derivatives |
10/27/1993 | CN1077710A Sulphonylbenzyl-substituted imidazoles |
10/27/1993 | CN1022565C Process for preparing piperazinylalkyl-3(2H)-pyridazinones |
10/26/1993 | US5256824 Substituted-amine compound and a process for the preparation thereof |
10/26/1993 | US5256789 Antiinflammatory hydroxamic acids and N-hydroxyureas |
10/26/1993 | US5256667 Quinazolinones and pyridopyrimidinones |
10/26/1993 | US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
10/26/1993 | CA2033975C Use of .beta.-receptor blocking agents |
10/26/1993 | CA1323572C Doxazosin as an anti-atherosclerosis agent |
10/20/1993 | EP0566542A1 Use of L-carnitine or acyl-L-carnitine in combination with an ACE-inhibitor for producing pharmaceutical composition for the treatment of cardiovascular disorders |
10/20/1993 | EP0566446A1 Derivatives of indane-1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy |
10/20/1993 | EP0566445A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy |
10/20/1993 | EP0566142A1 Inclusion complexes of optically active and racemic 1,4-dihydro pyridines with cyclodextrin derivates |
10/20/1993 | EP0566020A1 Benzimidazoles, pharmaceutical compositions thereof and processes for their preparation |
10/20/1993 | EP0566018A2 Benzoxazinone and benzothiazinone derivatives endowed with cardiovascular activity |
10/20/1993 | EP0565721A1 1,4-benzothiazepine derivative |
10/20/1993 | EP0565683A1 Quinoxaline derivates with affinity for quisqualate-receptors |
10/20/1993 | EP0565634A1 Angiotensin ii receptor blocking compositions |
10/20/1993 | EP0565582A1 Novel csaids |
10/20/1993 | EP0398925B1 Growth inhibiting agent and the use thereof |
10/20/1993 | EP0220241B1 Purified protein having angiogenic activity and methods of preparation |
10/20/1993 | CN1022460C Preparing process for inhalant |
10/19/1993 | US5254715 Anticholesterol agents |
10/19/1993 | US5254683 Neurological disorders |
10/19/1993 | US5254682 Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs |
10/19/1993 | US5254590 Acylaminophenol compounds |
10/19/1993 | US5254585 Use of peroxidized lipids for the preparation of a drug intended for the treatment of circulatory insufficiencies by local application |
10/19/1993 | US5254575 4-aryl-thiazole derivatives |
10/19/1993 | US5254574 Angiotensin II inhibitor |
10/19/1993 | US5254570 Acyl derivative of dianhydrohexitols |
10/19/1993 | US5254566 Decahydroquinoline compounds |
10/19/1993 | US5254564 Substituted isoquinoline compounds, pharmaceutical composition and method of use in treating pain in mammals |
10/19/1993 | US5254558 Treating respiratory system and cardiovascular disorders |
10/19/1993 | US5254549 New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
10/19/1993 | US5254546 Fused aryl substituted imidazole angiotensin II receptor inhibitors |
10/19/1993 | US5254544 Anticholesterol |
10/19/1993 | US5254543 Hypotensive, anticholesterol agents |
10/17/1993 | CA2092342A1 Benzoxazinone and benzothiazinone derivatives endowed with cardiovascular activity |
10/14/1993 | WO1993020088A1 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
10/14/1993 | WO1993020086A1 Process for producing derivatives of bis(aminomethyl) phosphinic acid |
10/14/1993 | WO1993020073A1 Indole derivatives as 5-ht1 agonists |
10/14/1993 | WO1993020066A1 Imidazole, triazole and tetrazole derivatives |
10/14/1993 | WO1993020059A1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
10/14/1993 | WO1993020058A1 Novel cardioprotective agents |
10/14/1993 | WO1993020057A1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols |
10/14/1993 | WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors |
10/14/1993 | WO1993020046A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for preparation of same and their use as therapeutic agents |
10/14/1993 | WO1993020045A1 Indan-1,3-dione and indan-1,2,3-trione derivatives, processes for the preparation of same and their application as therapeutic agents |
10/14/1993 | WO1993019805A1 Fibrin sealant delivery method |
10/14/1993 | WO1993019757A1 Use of phenothiazine derivatives for treating ischaemia and/or hypoxia |
10/14/1993 | WO1993019754A1 Phenol and pyridinol derivatives as lusitropic agents |
10/14/1993 | WO1993019753A1 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
10/14/1993 | WO1993019737A1 A pharmaceutical composition containing a defined lipid system |
10/14/1993 | DE4212529A1 Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten Use of μ-carbolines as a non-competitive glutamate antagonists |
10/14/1993 | CA2133076A1 Imidazole, triazole and tetrazole derivatives |
10/14/1993 | CA2132981A1 Phenol and pyridinol derivatives as lusitropic agents |
10/14/1993 | CA2129962A1 Therapeutic use of phenothiazine derivatives |
10/14/1993 | CA2117495A1 Fibrin sealant delivery method |
10/13/1993 | EP0565450A1 Use of peptide derivatives for the manufacture of medicaments inhibiting endopeptidases 24.15 and 24.16 |
10/13/1993 | EP0565317A1 (2-(2-hydroxy-2 phenylethylamino)ethoxy) phenyl derivatives, processes and intermediates for their preparation, pharmaceutical compositions containing them and their use as Beta-3-adrenoceptor agonists |
10/13/1993 | EP0565146A2 Use of a thioester for preparing pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes |
10/13/1993 | EP0564960A1 Imidazopyridines as angiotensin II antagonists |
10/13/1993 | EP0564788A2 Sulfonylbenzyl substituted imidazopyridines as AII-antagonists |
10/13/1993 | EP0564592A1 Liver enriched transcription factor |
10/13/1993 | EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters |
10/13/1993 | EP0564552A1 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
10/13/1993 | EP0458823B1 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines |
10/13/1993 | CN1077195A Sulphonylbenzyl-substituted imidazopyridines |
10/13/1993 | CN1077192A 2-oxoquinoline derivatives |
10/12/1993 | US5252753 Reacting phenyl tetrazole with Grignard reagant; angiotensin receptor antagonist |
10/12/1993 | US5252707 Inositol derivative and method for preparing same |
10/12/1993 | US5252601 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors |
10/12/1993 | US5252593 Pyrazole containing benzofuran derivatives and pharmaceutical compositions |
10/12/1993 | US5252591 Renin inhibitors |
10/12/1993 | US5252578 3-aminochroman compounds |